WO2019058904A1 - Composition d'agent antitranspiration - Google Patents

Composition d'agent antitranspiration Download PDF

Info

Publication number
WO2019058904A1
WO2019058904A1 PCT/JP2018/031834 JP2018031834W WO2019058904A1 WO 2019058904 A1 WO2019058904 A1 WO 2019058904A1 JP 2018031834 W JP2018031834 W JP 2018031834W WO 2019058904 A1 WO2019058904 A1 WO 2019058904A1
Authority
WO
WIPO (PCT)
Prior art keywords
component
mass
content
skin
antiperspirant
Prior art date
Application number
PCT/JP2018/031834
Other languages
English (en)
Japanese (ja)
Inventor
公樹 友松
Original Assignee
ライオン株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2018044089A external-priority patent/JP7049868B2/ja
Application filed by ライオン株式会社 filed Critical ライオン株式会社
Publication of WO2019058904A1 publication Critical patent/WO2019058904A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28—Zirconium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Definitions

  • the present invention relates to antiperspirant compositions.
  • Antiperspirant ingredients such as aluminum salts and bactericidal ingredients are used in roll-on type and lotion type antiperspirants that use water as a solvent. Furthermore, when adding an oil-based component for the purpose of giving a feeling etc., it is known that emulsifiers, such as nonionic surfactant, are used (for example, refer to patent documents 1). However, after applying such an antiperspirant to the skin, the solvent water volatilizes to cause the aluminum salt to be whitened on the skin, achieving both the antiperspirant effect and the absence of white remnant on the skin. There was a problem that it was difficult to do.
  • these components work synergistically, and after application of the antiperspirant composition, the skin becomes sticky, skin firmness, and skin It has been found that there is no irritation to the skin, the deodorizing effect and the stability of the preparation are excellent, and the white remnant of the skin can be suppressed while maintaining the antiperspirant effect.
  • the present invention is based on the findings by the present inventors, and means for solving the problems are as follows.
  • A at least one antiperspirant component selected from an aluminum compound, a zirconium compound, and a complex thereof
  • B a bactericidal component
  • C at least one selected from triglyceride (C1), fatty acid isoamyl (C2), and linear alkyl-modified silicone (C3);
  • D2 polyoxyethylene alkyl ether having an average added mole number of ethylene oxide of 10 or more and 30 or less
  • E containing water
  • the content of the component (E) is 65% by mass to 90% by mass.
  • the component (C1) and the component (C2) are contained, It is an antiperspirant composition as described in said ⁇ 1> whose mass ratio (C1 / C2) of content of said (C1) component and content of said (C2) component is 0.5-2 .
  • ⁇ 3> The antiperspirant composition according to any one of ⁇ 1> to ⁇ 2>, wherein the component (A) is chlorhydroxyaluminum.
  • ⁇ 4> The antiperspirant according to any one of ⁇ 1> to ⁇ 3>, wherein the component (B) is at least one selected from cetyl pyridinium chloride, benzalkonium chloride, and isopropyl methyl phenol It is a composition.
  • the component (C1) is at least one selected from tri (caprylic acid / capric acid) glyceryl and caprylic acid triglyceride
  • the component (C2) is at least one selected from isoamyl laurate, isoamyl caprate, and coconut oil fatty acid isoamyl
  • the antiperspirant composition according to any one of ⁇ 1> to ⁇ 4>, wherein the component (C3) is at least one selected from cetyl dimethicone, stearyl dimethicone, and caprylyl methicone.
  • the content of the component (A) is 7% by mass to 20% by mass
  • the content of the component (B) is 0.1% by mass to 0.3% by mass
  • the content of the component (C1) is 0.8% by mass to 2% by mass
  • the content of the component (C2) is 0.8% by mass to 2% by mass
  • the content of the component (C3) is 1% by mass to 3% by mass
  • the content of the component (D1) is 1.5% by mass to 3.5% by mass
  • the content of the component (D2) is 1.5% by mass to 2.5% by mass
  • the antiperspirant composition according to any one of ⁇ 1> to ⁇ 5>, wherein a content of the component (E) is 70% by mass to 85% by mass.
  • the mass ratio (D1 / D2) of the content of the ⁇ 7> component (D1) to the content of the component (D2) is 0.7 to 2.0, and the mass ratio of ⁇ 1> to ⁇ 6> It is an antiperspirant composition in any one. It is an antiperspirant composition in any one of said ⁇ 1> to ⁇ 7> which is either ⁇ 8> roll-on type and a lotion type.
  • the above-mentioned various problems in the prior art can be solved and the above object can be achieved, and there is no stickiness of the skin after application of the antiperspirant composition, no feeling of skin tightness and skin irritation, deodorizing effect And while being excellent in the stability of a formulation, the antiperspirant composition which can suppress the white remnant of skin can be provided, maintaining an antiperspirant effect.
  • the antiperspirant composition of the present invention is selected from (A) antiperspirant component, (B) bactericidal component, (C) triglyceride (C1), fatty acid isoamyl (C2), and linear alkyl-modified silicone (C3) (D1) polyoxyethylene alkyl ether having an average addition mole number of 2 or more and 8 or less, (D2) polyoxyethylene alkyl ether having an average addition mole number of 10 to 30 of (D1) ethylene oxide, And (E) contains water, and further contains other components as required.
  • the antiperspirant component of the component (A) is at least one selected from an aluminum compound, a zirconium compound, and a complex thereof.
  • the antiperspirant component of the component (A) is contained to impart an antiperspirant effect.
  • Examples of the aluminum compound, zirconium compound, and complexes thereof include aluminum chloride, aluminum sulfate, aluminum potassium sulfate, aluminum acetate, chlorohydroxyaluminum, allantoin chlorohydroxyaluminum, chlorohydroxyaluminum / propylene glycol complex, chlorohydroxyaluminum / Examples thereof include zirconium and glycine complexes. These may be used alone or in combination of two or more. Among these, chlorohydroxyaluminum and chlorohydroxyaluminum / propylene glycol complex are preferable, and chlorohydroxyaluminum is more preferable, in that the antiperspirant effect is more excellent.
  • an antiperspirant component of said (A) component There is no restriction
  • the commercially available products include chlorhydroxyaluminum (trade name: chlorhydroxyaluminum, manufactured by Takaki Chemical Co., Ltd.), chlorhydroxyaluminum / propylene glycol complex (trade name: REHYDROL II, manufactured by Summit Reheis), and aluminum potassium sulfate (Trade name: potassium alum, manufactured by Daimei Chemical Industries, Ltd.), chlorhydroxyaluminum / zirconium-glycine complex (trade name: Reach AZO-956G, manufactured by Summit Reheis), and the like.
  • the content of the antiperspirant component of the component (A) is 5% by mass with respect to the total amount of the antiperspirant composition from the viewpoint of antiperspirant effect, lack of skin firmness and non-stickiness of the skin 25% by mass is preferable, and 7% by mass to 20% by mass is more preferable.
  • the content is less than 5% by mass, the antiperspirant effect may be insufficient, and when it exceeds 25% by mass, the feeling of skin firmness and the feeling of stickiness of the skin become insufficient. Sometimes.
  • the sterilizing component of the component (B) is contained to impart a deodorizing effect.
  • Examples of the sterilizing component of the component (B) include cetyl pyridinium chloride, benzalkonium chloride, isopropyl methyl phenol and the like. These may be used alone or in combination of two or more. Among these, cetyl pyridinium chloride and benzalkonium chloride are preferable in terms of the deodorizing effect.
  • the sterilizing component of the component (B) for example, cetyl pyridinium chloride (trade name: cetyl pyridinium chloride, manufactured by Wako Pure Chemical Industries, Ltd.), benzalkonium chloride (trade name: trizone solution, Yamada Pharmaceutical Co., Ltd.) And Isopropylmethylphenol (trade name: isopropylmethylphenol, manufactured by Osaka Kasei Co., Ltd.).
  • cetyl pyridinium chloride trade name: cetyl pyridinium chloride, manufactured by Wako Pure Chemical Industries, Ltd.
  • benzalkonium chloride trade name: trizone solution, Yamada Pharmaceutical Co., Ltd.
  • Isopropylmethylphenol trade name: isopropylmethylphenol, manufactured by Osaka Kasei Co., Ltd.
  • the content of the component (B) is preferably 0.05% by mass to 0.5% by mass, based on the total amount of the antiperspirant composition, from the viewpoint of deodorizing effect and no irritation to the skin. 1% by mass to 0.3% by mass is more preferable. If the content is less than 0.05% by mass, the deodorizing effect may be insufficient. If the content is more than 0.5% by mass, the lack of skin irritation may be insufficient.
  • Component (C) At least one selected from triglyceride (C1), fatty acid isoamyl (C2), and linear alkyl-modified silicone (C3)> Component (C): at least one selected from triglyceride (C1), fatty acid isoamyl (C2), and linear alkyl-modified silicone (C3) is included to impart whiteness of the skin Ru. It is preferable that the said (C) component uses together the said (C1) component and the said (C2) component.
  • Examples of the triglyceride of the component (C1) include glyceryl tri (caprylic acid ⁇ capric acid), caprylic acid triglyceride and the like. These may be used alone or in combination of two or more. Among these, tri (caprylic acid / capric acid) glyceryl is preferable from the viewpoint of no whitening of the skin.
  • Examples of the fatty acid isoamyl of the component (C2) include isoamyl laurate, isoamyl caprylate, isoamyl caprate, coconut oil fatty acid isoamyl and the like. These may be used alone or in combination of two or more. Among these, isoamyl laurate, isoamyl caprate and coconut oil fatty acid isoamyl are preferable, and isoamyl laurate is more preferable, from the viewpoint of no whitening of the skin.
  • linear alkyl-modified silicone of the component (C3) examples include cetyl dimethicone, stearyl dimethicone and caprylyl methicone. These may be used alone or in combination of two or more. Among these, cetyl dimethicone is preferable from the viewpoint of no whitening of the skin.
  • Examples of commercially available products of the component (C1) include glyceryl tri (caprylic acid and capric acid) (trade name: CRODAMOL GTCC, manufactured by Croda Japan KK), caprylic acid triglyceride (trade name: tricaprylin, Tokyo Chemical Industry Co., Ltd.) Company-made).
  • Examples of commercial products of the component (C2) include isoamyl laurate (trade name: isoamyl laurate, manufactured by Tokyo Chemical Industry Co., Ltd.), and isoamyl caprylate (trade name: isoamyl caprylate, manufactured by Tokyo Chemical Industry Co., Ltd.) And isoamyl caprylate (trade name: isoamyl caprate, manufactured by Tokyo Chemical Industry Co., Ltd.), coconut oil fatty acid isoamyl (trade name: TEGOSOFT AC, manufactured by Evonik Nutrition & Care GmbH), and the like.
  • Examples of commercial products of the component (C3) include cetyl dimethicone (trade name: ABIL WAX 9801, manufactured by Evonik Nutrition & Care GmbH), stearyl dimethicone (trade name: ABIL WAX 9800, manufactured by Evonik Nutrition & Care GmbH) And caprylyl methicone (trade name: FZ-3196, manufactured by Toray Dow Corning Co., Ltd.).
  • the content of the component (C1) is 0.5% by mass to 3% with respect to the total amount of the antiperspirant composition from the viewpoint of no whitening of the skin, stability of the preparation, and no stickiness of the skin. % By mass is preferable, and 0.8% by mass to 2% by mass is more preferable. When the content is less than 0.5% by mass, the lack of whiteness of the skin may be insufficient, and when it exceeds 3% by mass, the stability of the preparation and the non-stickiness of the skin may not be sufficient. It may be enough.
  • the content of the component (C2) is 0.5% by mass to 3% with respect to the total amount of the antiperspirant composition from the viewpoint of no whitening of the skin, stability of the preparation, and no stickiness of the skin. % By mass is preferable, and 0.8% by mass to 2% by mass is more preferable. When the content is less than 0.5% by mass, the lack of whiteness of the skin may be insufficient, and when it exceeds 3% by mass, the stability of the preparation and the non-stickiness of the skin may not be sufficient. It may be enough.
  • the content of the component (C3) is preferably 0.5% by mass to 5% by mass, based on the total amount of the antiperspirant composition, from the viewpoint of no whitening of the skin and the stability of the preparation. % To 3% by mass is more preferable. When the content is less than 0.5% by mass, the lack of whiteness of the skin may be insufficient, and when it exceeds 5% by mass, the stability of the preparation may be insufficient.
  • the mass ratio (C1 / C2) of the content of the component (C1) to the content of the component (C2) is 0.3 to 3 in view of the stability of the preparation and no stickiness of the skin. 6 is preferable, and 0.5 to 2 is more preferable. When the mass ratio is less than 0.3 or more than 3.6, the stability of the preparation and the tackiness of the skin may be insufficient.
  • the polyoxyethylene alkyl ether of the component (D) has an average addition mole number of (D1) ethylene oxide of 2 or more and 8 or less, and an average addition mole number of (D2) ethylene oxide of 10 or more and 30.
  • the following polyoxyethylene alkyl ether is contained.
  • the component (D) is included to improve the stability of the preparation.
  • the average addition mole number of the polyoxyethylene alkyl ether having an average addition mole number of 2 to 8 of ethylene oxide of the component (D1) is preferably 2 to less than 5 from the viewpoint of the stability of the preparation. When the average addition mole number exceeds 8, the stability of the preparation may be insufficient. There is no commercially available product available for polyoxyethylene alkyl ethers in which the average addition mole number of ethylene oxide is less than 2.
  • the average addition mole number of the ethylene oxide in the component (D2) is 10 to 30 and the average addition mole number of the polyoxyethylene alkyl ether is 10 to 30 from the viewpoint of stability of the preparation and no stickiness of the skin.
  • the following are preferred.
  • the average addition mole number is less than 10, the stability of the preparation may be insufficient, and when the average addition mole number exceeds 30, the stability of the preparation and the non-greasy skin are insufficient. It can be
  • the polyoxyethylene alkyl ether having an average addition mole number of ethylene oxide of 2 to 8 as the component (D1) is not particularly limited and may be appropriately selected according to the purpose.
  • the average addition of ethylene oxide is The polyoxyethylene stearyl ether etc. whose number-of-moles are 2 or more and 8 or less are mentioned.
  • polyoxyethylene alkylether in which the average added mole number of the ethylene oxide of the said (D2) component is 10-30, can be selected suitably according to the objective,
  • the average addition of ethylene oxide The polyoxyethylene stearyl ether etc. whose mole number is ten or more and 30 or less are mentioned.
  • Steareth-2 (trade name: EMALEX 602) and Steareth-3 (trade name: EMALEX 603)
  • Steareth-5 trade name: EMALEX 605
  • Steareth-8 (trade name: EMALEX 608) (all manufactured by Nippon Emulsion Co., Ltd.), and the like.
  • Steareth-11 (trade name: EMALEX 611) and Steareth-15, wherein the average addition mole number of ethylene oxide is 11, 15, 16, 20, 25 and 30, respectively.
  • EMALEX 615 (trade name: EMALEX 615), Steareth-16 (trade name: EMALEX 616), Steareth -20 (trade name: EMALEX 620), Steareth-25 (trade name: EMALEX 625), Steareth-30 (trade name: EMALEX 630) (all of which are Nippon Emulsion Co., Ltd.) and the like.
  • the content of the component (D1) is preferably 1% by mass to 5% by mass, and preferably 1.5% by mass, with respect to the total amount of the antiperspirant composition, in terms of stability of the preparation and no stickiness of the skin. % To 3.5% by mass is more preferable. If the content is less than 1% by mass, the stability of the preparation may be insufficient. If it is more than 5% by mass, the tackiness of the skin may be insufficient.
  • the content of the component (D2) is preferably 1% by mass to 3% by mass, and preferably 1.5% by mass, with respect to the total amount of the antiperspirant composition, from the viewpoint of stability of the preparation and tackiness of the skin. % To 2.5% by mass is more preferable. If the content is less than 1% by mass, the stability of the preparation may be insufficient, and if it is more than 3% by mass, the skin tackiness may be insufficient.
  • the mass ratio (D1 / D2) of the content of the component (D1) to the content of the component (D2) is preferably 0.4 to 4.0 from the viewpoint of the stability of the preparation, and 0. 7 to 2.0 is more preferable. If the mass ratio is less than 0.4 or more than 4.0, the stability of the preparation may be insufficient.
  • the water of the component (E) is contained to impart stability of the preparation.
  • the content of water of the component (E) is 65% by mass to 90% by mass with respect to the total amount of the antiperspirant composition from the viewpoint of stability of the preparation and no stickiness of the skin, 70% by mass % To 85% by mass is preferable.
  • the content is less than 65% by mass, the stability of the preparation may be insufficient, and when it is more than 90% by mass, the smoothness of the skin may be insufficient.
  • the content of water of the component (E) is the total content including the water carried from these components when the components (A) to (D) and the other components are blended. .
  • the antiperspirant composition of the present invention is usually added to the antiperspirant composition according to the dosage form as long as the effects of the present invention are not impaired.
  • Other ingredients can be added.
  • limiting in particular as said other component According to the objective, it can select suitably, For example, a fats-and-oils compound, a wax compound, a silicone compound, hydrocarbon oil, a higher fatty acid, a higher alcohol, except the said (D) component
  • limiting in particular as content of said other component According to the objective, it can select suitably in the range which does not prevent the
  • the pH of the antiperspirant composition at 25 ° C. is preferably 3 to 4.5 from the viewpoint of antiperspirant effect, no irritation to the skin and stability of the preparation. If the pH is less than 3, the antiperspirant effect and the lack of skin irritation may be insufficient, and if it exceeds 4.5, the stability of the preparation may be insufficient.
  • a viscosity of the said antiperspirant composition there is no restriction
  • the viscosity is measured, for example, at 25 ° C. using a BL viscometer at 25 ° C. It can be measured at 60 rpm for 1 minute using 1 to 4 rotors.
  • an emulsion is obtained by mixing an oil phase containing the component (C) and the component (D) with an aqueous phase containing the component (E) under the temperature condition equal to or higher than the melting point of the component (D) And then, if necessary, by adding and mixing the (A) component and the (B) component to the obtained emulsion.
  • an apparatus which prepares the said antiperspirant composition there is no restriction
  • the components (A) to (E) and the other components may be used alone or as a mixture containing two or more components. You may use it in the state of.
  • a dosage form of the said antiperspirant composition For example, semi-solid type, gel-like type, liquid type etc. are mentioned. Among them, gel-type and liquid-type are preferable in that they are applied to the skin in a state dissolved in water, which is effective for exhibiting the effect, can be applied in high adhesion, and can exhibit high antiperspirant effect. Type is more preferred.
  • As said semi-solid type a cream type etc. are mentioned, for example.
  • a gel-like type, gel type etc. are mentioned, for example.
  • a roll on type, a lotion type, a mist type etc. are mentioned, for example. Among these, roll-on type and lotion type are preferable in terms of antiperspirant effect.
  • the antiperspirant product comprises the antiperspirant composition and a coating ball, and comprises a roll-on container filled with the antiperspirant composition.
  • the roll-on type preparation is contained in a known roll-on container, and the antiperspirant composition is attached to the coating ball held in a holder rotatably with a part thereof exposed in the roll-on container,
  • the application ball can be attached to the skin and applied at the time of use.
  • a gel preparation which is filled with the antiperspirant composition in a bottle container and applied as it is using a container; a gel preparation which is applied using a fingertip or a hand, and a lotion preparation can also be suitably used.
  • the container examples include a roll-on container, a bottle container for gel, a bottle container for lotion, and a trigger type spray container for mist.
  • roll-on containers are preferable in terms of antiperspirant effect.
  • the roll-on container can be suitably used in that the antiperspirant composition can be applied in close contact with the skin and the antiperspirant effect can be exhibited.
  • the roll-on container is not particularly limited as long as it can be filled with the antiperspirant composition, and can be appropriately selected according to the purpose. For example, those described in JP-A-2005-186997 and the like Can be mentioned.
  • a bottle material: HDPE natural, full filling internal volume: about 56 mL, body diameter: about 33 mm, height: about 87 mm, made by Yoshino Kogyo Co., Ltd.
  • ring material: LLDPE natural, Outer diameter: about 26 mm, height: about 18 mm, manufactured by Yoshino Industry Co., Ltd.
  • ball material: PP white, diameter: about 20 mm, manufactured by Yoshino Industrial Co., Ltd.
  • a bottle for example, a bottle (trade name: TOM III-50, material: HDPE natural, full filling volume: about 34 mL, body diameter: about 42 mm ⁇ 29 mm (oval), height: about 88 mm, Takemoto Container Co., Ltd.), inside plug (product name: TO cap nozzle A, material: PE natural, outer diameter: about 12 mm, height: about 13 mm, product made by Takemoto Container Co., Ltd.), cap (product name: TOM III cap, Material: PP white, outer diameter: about 37 mm ⁇ 25 mm (oval), height: about 24 mm, manufactured by Takemoto Container Co., Ltd.) or the like can be used.
  • TOM III-50 material: HDPE natural, full filling volume: about 34 mL, body diameter: about 42 mm ⁇ 29 mm (oval), height: about 88 mm, Takemoto Container Co., Ltd.
  • inside plug product name: TO cap nozzle A, material: PE natural, outer diameter: about 12 mm, height: about 13
  • the antiperspirant composition of the present invention is excellent in the deodorizing effect and the stability of the preparation as well as the antiperspirant effect, since it is not sticky after the application of the antiperspirant composition, there is no skin firmness and skin irritation.
  • whiteness of the skin can be suppressed while maintaining it, for example, it can be applied to cosmetics, medicines, quasi-drugs, etc., and it can be used as an antiperspirant, deodorant, antiperspirant, deodorant and deodorant. It is suitably available.
  • Examples 1 to 57 and Comparative Examples 1 to 10 The antiperspirant compositions of Examples 1 to 57 and Comparative Examples 1 to 10, which have the compositions shown in Tables 1 to 10 below, were prepared by an ordinary method. 40 mL of each obtained antiperspirant composition was filled in a roll-on container of the following specification to make a roll-on type antiperspirant composition.
  • the antiperspirant effect for each of the roll-on type antiperspirant compositions obtained, the antiperspirant effect, the deodorizing effect, the non-whitening of the skin, the non-stickiness of the skin, and the non-toughness of the skin, as follows: The no irritation to the skin and the stability of the formulation were evaluated. The results are shown in Tables 1 to 10.
  • Formulation stability (freeze and rehydrate stability) 40 g of each of the prepared antiperspirant compositions was filled in a 50 g capacity soft transparent glass bottle (trade name: SV-50A, manufactured by Niommen Chemical Glass Co., Ltd.) and completely frozen by storing at -20 ° C. for 1 day After that, it was left to stand at room temperature for 1 day to naturally thaw. After repeating this operation 5 times, "the stability of the preparation" as the freeze recovery stability was evaluated based on the following evaluation criteria. -Evaluation criteria of formulation stability- ⁇ : no syneresis and no separation at all ⁇ : very slight syneresis but not separation O: no syneresis but not separation ⁇ : very slight separation X: separation is observed
  • the antiperspirant composition of the present invention is excellent in the deodorizing effect and the stability of the preparation as well as the antiperspirant effect, since it is not sticky after the application of the antiperspirant composition, there is no skin firmness and skin irritation. Since whiteness of the skin can be suppressed while maintaining it, it can be applied to, for example, cosmetics, medicines, quasi-drugs, etc.
  • Antiperspirant, deodorant, antiperspirant, deodorant, etc. Can be suitably used.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

L'invention fournit une composition d'agent antitranspiration qui comprend (A) au moins une sorte de composant antitranspiration choisie parmi un composé aluminium, un composé zirconium et leurs complexes, (B) un composant désinfectant, (C) au moins un élément choisi parmi un triglycéride (C1), un isoamyle d'acide gras (C2) et une silicone modifiée par un alkyle (C3), (D1) un polyoxyéthylène alkyl éther de nombre moyen de moles ajoutés d'oxyde d'éthylène supérieur ou égal à 2 et inférieur ou égal à 8, (D2) un polyoxyéthylène alkyl éther de nombre moyen de moles ajoutés d'oxyde d'éthylène supérieur ou égal à 10 et inférieur ou égal à 30, et (E) une eau, la teneur en composant (E) étant comprise entre 65 et 90% en masse.
PCT/JP2018/031834 2017-09-21 2018-08-28 Composition d'agent antitranspiration WO2019058904A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2017-181210 2017-09-21
JP2017181210 2017-09-21
JP2018044089A JP7049868B2 (ja) 2017-09-21 2018-03-12 制汗剤組成物
JP2018-044089 2018-03-12

Publications (1)

Publication Number Publication Date
WO2019058904A1 true WO2019058904A1 (fr) 2019-03-28

Family

ID=65811369

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/031834 WO2019058904A1 (fr) 2017-09-21 2018-08-28 Composition d'agent antitranspiration

Country Status (1)

Country Link
WO (1) WO2019058904A1 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001503039A (ja) * 1996-10-19 2001-03-06 バイヤースドルフ・アクチエンゲゼルシヤフト 高度に水和された制汗および／またはデオドラントスティック
JP2009046426A (ja) * 2007-08-20 2009-03-05 Shiseido Co Ltd 皮膚外用剤
JP2012506844A (ja) * 2008-10-27 2012-03-22 ユニリーバー・ナームローゼ・ベンノートシヤープ 制汗剤または脱臭剤組成物
JP2014503586A (ja) * 2011-01-24 2014-02-13 アンテリオス， インコーポレイテッド 油組成物
US20170202770A1 (en) * 2016-01-15 2017-07-20 Evonik Degussa Gmbh Composition comprising polyglycerol esters and hydroxyalkyl-modified guar

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001503039A (ja) * 1996-10-19 2001-03-06 バイヤースドルフ・アクチエンゲゼルシヤフト 高度に水和された制汗および／またはデオドラントスティック
JP2009046426A (ja) * 2007-08-20 2009-03-05 Shiseido Co Ltd 皮膚外用剤
JP2012506844A (ja) * 2008-10-27 2012-03-22 ユニリーバー・ナームローゼ・ベンノートシヤープ 制汗剤または脱臭剤組成物
JP2014503586A (ja) * 2011-01-24 2014-02-13 アンテリオス， インコーポレイテッド 油組成物
US20170202770A1 (en) * 2016-01-15 2017-07-20 Evonik Degussa Gmbh Composition comprising polyglycerol esters and hydroxyalkyl-modified guar

Similar Documents

Publication Publication Date Title
JP3657395B2 (ja) 外用組成物
MX2008001954A (es) Composiciones antitranspirantes.
JP6553454B2 (ja) 制汗剤組成物
EP2405885A1 (fr) Compositions d'additif épaississant
JP6900122B2 (ja) 制汗剤組成物、及び制汗剤
WO2019058904A1 (fr) Composition d'agent antitranspiration
JP7049868B2 (ja) 制汗剤組成物
JP6900121B2 (ja) 制汗剤組成物、及び制汗剤
EP1486199A1 (fr) Composition déodorante aérosol alcoolique contenant le salicylate de zinc ou l'un de ses dérivés
JP7009088B2 (ja) 制汗剤組成物
JP5951155B1 (ja) 乳化デオドラント組成物およびデオドラント剤
JP6594759B2 (ja) 制汗剤組成物
JP6909179B2 (ja) 油性化粧料
JP6893485B2 (ja) クレンジング化粧料
JP3675637B2 (ja) 外用組成物
JP6660258B2 (ja) 制汗剤組成物
JP2021091613A (ja) 油性皮膚保護剤
JP3649619B2 (ja) 外用組成物
EP0946135B1 (fr) Composition non-aqueuse antisudorale
JP2022096800A (ja) 制汗剤組成物
JP7101097B2 (ja) 制汗剤組成物
JP7309400B2 (ja) 乳化化粧料組成物
JP2013075870A (ja) 乳化型制汗化粧料
JP6614071B2 (ja) 液体口腔用組成物
JP3649620B2 (ja) 外用組成物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18859278

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18859278

Country of ref document: EP

Kind code of ref document: A1